×
For best experience we recommend to activate Javascript in your browser.
MAP1LC3A antibody (PE)
The PE-conjugated Mouse Monoclonal anti-MAP1LC3A antibody (Clone 166AT1234) (ABIN6754226) specifically detects MAP1LC3A in WB, IHC, ELISA and ICC.
The antibody is reactive with Human samples.
Catalog No. ABIN6754226
$1,480.60
Plus shipping costs $50.00
Delivery in 11 to 14 Business Days
Quick Overview for MAP1LC3A antibody (PE) (ABIN6754226)
Target
See all MAP1LC3A Antibodies
MAP1LC3A
(Microtubule-Associated Protein 1 Light Chain 3 alpha (MAP1LC3A))
Reactivity
All reactivities for MAP1LC3A antibodies
Human
Host
All hosts for MAP1LC3A antibodies
Mouse
Clonality
All clonalities for MAP1LC3A antibodies
Monoclonal
Conjugate
All conjugates for MAP1LC3A antibodies
This MAP1LC3A antibody is conjugated to PE
Application
All applications for MAP1LC3A antibodies
Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunocytochemistry (ICC)
Clone
166AT1234
Product Details anti-MAP1LC3A Antibody (PE)
(hide)
Specificity
Human MAP1LC3A / LC3A.
Cross-Reactivity
Mouse (Murine), Rat (Rattus)
Purification
Protein G purified
Immunogen
Recombinant human LC3. ImmunogenType: Recombinant protein
Isotype
IgG1 kappa
Alternatives
(show)
Application Details
(hide)
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
PBS, pH 7.2, 0.09% sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Storage
4 °C
Storage Comment
May be stored at 4°C for short-term only. For long-term storage, store at -20°C. Aliquots are stable for at least 6 months at -20°C.
Target Details for MAP1LC3A
(hide)
Target
MAP1LC3A
(Microtubule-Associated Protein 1 Light Chain 3 alpha (MAP1LC3A))
Alternative Name
MAP1LC3A / LC3A
Background
Synonyms: MAP1LC3A, ATG8E, LC3, LC3A, MAP1BLC3, MAP1A/1B light chain 3 A, MAP1A/MAP1B LC3 A, MAP1A/MAP1B light chain 3 A, MAP1ALC3
Gene ID
84557
Pathways
Autophagy
Recently viewed
(hide)
Chat with us , powered by LiveChat